Who has invested in Stoke Therapeutics?

Apple Tree Partners are named among the investors backing Stoke Therapeutics.

Stoke Therapeutics Funding: $40M Raised, Series A (2018)

Stoke Therapeutics funding overview

Stoke Therapeutics is based in Bedford, Massachusetts. Stoke Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2018. The round record for Stoke Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Apple Tree Partners.

Stoke Therapeutics at a glance

Total raised: $40M
Latest round: Series A
Latest round date: January 2018
Headquarters: Bedford, Massachusetts
Notable investors: Apple Tree Partners

Frequently asked about Stoke Therapeutics funding

How much has Stoke Therapeutics raised?: Stoke Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Stoke Therapeutics?: Apple Tree Partners are named among the investors backing Stoke Therapeutics.
What was the latest Stoke Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2018.
Where is Stoke Therapeutics based?: Stoke Therapeutics is based in Bedford, Massachusetts.
When did Stoke Therapeutics last raise?: The last disclosed Stoke Therapeutics round closed in January 2018 at Series A.

Every Stoke Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Bedford at a similar stage.

Stoke Therapeutics Funding: $40M Raised, Series A (2018)

Stoke Therapeutics funding overview

Stoke Therapeutics at a glance

Frequently asked about Stoke Therapeutics funding

Companies related to Stoke Therapeutics (21)

Browse related funding lists (4)